People living with MDR-TB and their healthcare providers call for urgent action If measures to tackle multidrug-resistant tuberculosis (MDR-TB) are not significantly stepped up, including addressing barriers that prevent both research into better drug combinations and treatment scale up, MDR-TB...
“I felt like I had bugs crawling on the inside of my head”. The highly toxic pills and daily injections that Mary was taking made her vomit, lose her appetite and hallucinate. And it was MSF doctors who were telling her she had to keep on taking them, had to bear all those “side effects” in the...
MSF calls for rapid registration in countries with high drug-resistant tuberculosis burden Médecins Sans Frontières (MSF) welcomed the approval by the US Food and Drug Administration of bedaquiline, the first new drug active against tuberculosis (TB) to be registered since 1963. “The first new drug...
New MSF multinational study of paediatric TB/HIV co-infection confirms crisis of undiagnosed TB among children Data from the largest-ever multinational cohort of children infected with both tuberculosis (TB) and HIV, released by the international medical humanitarian organisation Médecins Sans...
Results from the largest multi-country implementation of the new rapid tuberculosis (TB) diagnostic test reveal an urgent need to address the growing global crisis of drug-resistant TB (DR-TB), according to the international medical humanitarian organisation Médecins Sans Frontières (MSF). The data...
Many patients with drug-resistant TB that arrive at MSF’s clinic in Mumbai have received incorrect or inadequate treatment in the private sector. Although this form of TB is curable if treated early enough, some of the patients, like ‘Shanti’*, are in such bad condition that their lives cannot be...
DR Congo: An alarming surge in malaria Chad: On the brink of a peak in malnutrition Paraguay: The scourge of the vinchuca Uzbekistan: Tuberculose shows resistance Haiti: Medical certificates for cholera patients
Maternal health: Saving women's lives Dadaab: Back to square one Tuberculosis: A constant battle Sleeping sickness: A mobile team in central Africa Novartis: The final act
Alarming new data suggest that the global scope of multidrug-resistant tuberculosis (MDR-TB) is much more vast than previously estimated, requiring a concerted international effort to combat this deadlier form of the disease, the medical humanitarian organisation Médecins Sans Frontières (MSF) said...
In a report released today Médecins Sans Frontières (MSF), the largest provider of HIV treatment in Myanmar (1), highlights the critical need for increased HIV and Tuberculosis (TB), including multidrug-resistant tuberculosis (MDR-TB), treatment in the country. According to the report, 85,000...
